Drug · DIN 02285967
TEVA-ACYCLOVIR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 25, 2011; first marketed October 23, 2006.
- Drug Identification Number (DIN)
- 02285967
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Acyclovir J05AB01
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ACYCLOVIR | 400 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 24, 2011: NOC 12023Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- September 22, 2006: NOC 8277Abbreviated New Drug Submission (ANDS)
Other DINs named TEVA-ACYCLOVIR
- DIN 02285959 · Marketed
- DIN 02285975 · Marketed